DOSSIER · UPDATED 18 NOV 2025

Rapport Therapeutics

Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding,…

rapportrx.com ↗Claim this profile

Founded: 2022
Headcount: 43
Open roles: 8
Last raised: Post Ipo Equity · $250M

SECTION I · THE BRIEF

Inside Rapport Therapeutics

Brief #97376Updated 18 NOV 2025BOSTONMEDICAL ORGANIZATIONSPOST IPO EQUITY

Employbl Dossier

Rapport Therapeutics

Founded: 2022
Headcount: 43
Open roles: 8
Last raised: Post Ipo Equity · $250M

Section II · Premium ProfileMembers only

01Engineering interview process at Rapport TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Rapport Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Steven Paul

David Bredt

OPEN ROLES

Hiring at Rapport Therapeutics

View all 8 open roles →

FUNDING

Capital raised

Total Amount Raised: $250,000,000

Rapport Therapeutics Funding Rounds

Post Ipo Equity
$250,000,000
Sep 9, 2025
IPO
Unknown
Jan 1, 2024
Series B
$150,000,000
Aug 23, 2023
Series B
$150,000,000
Aug 22, 2023
Series B Investors
Cormorant Asset Management
Arch Venture Partners
Fidelity
Logos Capital
Third Rock Ventures
Perceptive Advisors
Goldman Sachs Asset Management
Surveyor Capital
Johnson & Johnson Innovation
Sofinnova Ventures
T. Rowe Price
Series A
$100,000,000
Mar 7, 2023
Series A
$100,000,000
Mar 6, 2023
Series A Investors
Third Rock Ventures
Arch Venture Partners
Johnson & Johnson Innovation